Your browser doesn't support javascript.
loading
The Impact of Door to Diuretic Time in Acute Heart Failure on Hospital Length of Stay and In-Patient Mortality.
Iqbal, Arshad Muhammad; Mohammed, Sohaib K; Zubair, Nida; Mubarik, Ateeq; Ahmed, Adnan; Jamal, Syed Farrukh; Hassan, Syed Moin; Haq, Furqan; Muddassir, Salman.
Afiliação
  • Iqbal AM; Internal Medicine, University of South Florida Morsani College of Medicine Graduate Medical Education (GME) Oak Hill Hospital, Brooksville, USA.
  • Mohammed SK; Cardiology/Electrophysiology, University of Missouri School of Medicine, Columbia, USA.
  • Zubair N; Internal Medicine, Deccan College of Medical Sciences, Hyderabad, IND.
  • Mubarik A; Internal Medicine, Dow Medical College and Civil Hospital, Karachi, PAK.
  • Ahmed A; Internal Medicine, Oak Hill Hospital, Brooksville, USA.
  • Jamal SF; Sleep Medicine, New York Sleep Disorder Center, Brooksville, USA.
  • Hassan SM; Internal Medicine, Ascension St. Michael's Hospital, Stevens Point, USA.
  • Haq F; Internal Medicine, Saint Joseph Hospital, Chicago, USA.
  • Muddassir S; Cardiology, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE.
Cureus ; 13(1): e12742, 2021 Jan 16.
Article em En | MEDLINE | ID: mdl-33643721
ABSTRACT
Background Acute heart failure (AHF) can be life-threatening if not treated promptly and can significantly increase the number of annual emergency department (ED) encounters in the United States. Achieving adequate and prompt euvolemic state in AHF patients using intravenous (IV) diuretics is the cornerstone of treatment, which not only reduces in-hospital stay and mortality but also decreases healthcare expenditures. Surprisingly, the door to diuretic (D2D) time in AHF patients has always been a debatable issue among physicians worldwide, and so far, there are no set guidelines. This study examines a large cohort of AHF patients to determine the association between diuretics use within 90 minutes of ED admission and hospital length of stay (LOS) and patient mortalityMethods Retrospective institutional data of AHF patients receiving IV diuretics following ED admission were extracted from 2016 to 2017. A total of 7,751 patients treated for AHF exacerbation were included, which were further divided into two groups based on the timing of diuretics administration (<90 minutes vs. ≥90 minutes). The primary outcomes were LOS between the two groups and hospital mortality. The standard statistical methodology was used for data analysis. Results  A total of 7,751 AHF cases receiving IV diuretics were identified. Almost 1,432 patients (18.5%) received IV diuretics within 90 minutes of ER admission (group 1) while 6,319 patients (81.5%) patients received IV diuretics after 90 minutes (group 2). Furthermore, among group 1 patients, average LOS was noted to be associated with shorter hospitalization (average of 1.423 days less as compared to group 2 patients (confidence interval (CI) =1.02-1.82; p<0.05). Finally, after controlling for other mortality risk factors, patients in group 2 were 1.435 times more likely to have died compared to patients in group 1 (CI=1.03-1.98; p<0.05). Conclusions  D2D time in AHF patients has always been a crucial judgmental decision. The current study successfully demonstrated the relation between IV diuretics administration within 90 minutes of ED admission, favorable clinical outcomes, and decreased mortality rates. More adequately powered studies are needed to validate the results of our current study further.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cureus Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cureus Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos